πŸ‡ΊπŸ‡Έ FDA
Patent

US 8372812

Phospholipid and protein tablets

granted A61KA61K31/122A61K31/685

Quick answer

US patent 8372812 (Phospholipid and protein tablets) held by Aker Biomarine AS expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aker Biomarine AS
Grant date
Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/122, A61K31/685, A61K35/612, A61K9/2009